China's AI-Native Eye Clinic Reveals Critical Workflow Lessons for Autonomous Care
The integration of artificial intelligence into clinical medicine has long been discussed in theory, but real-world…
The integration of artificial intelligence into clinical medicine has long been discussed in theory, but real-world…
Real-time tissue diagnosis during surgery has long been a bottleneck where speed and accuracy are in direct tension…
Fibrosis is biology's compromise: when human tissue is damaged, scar formation plugs the wound but leaves behind…
Biological age estimation is undergoing a quiet revolution — one that matters because the gap between chronological…
For the estimated 39 million people living with HIV globally — many now reaching older age thanks to antiretroviral…
Growth-related knee pain is quietly undermining youth athletic development, yet the field has lacked good data on…
Wildland firefighters already face elevated cancer rates — a finding now reinforced by growing evidence that the smoke…
For the millions of adults living with chronic obstructive pulmonary disease, every exacerbation carries real risk…
Tuberculosis remains one of humanity's most persistent killers, yet the pace of progress toward elimination targets is…
In 14,212 adults aged 45–74 from the Hamburg City Health Study, complete left bundle branch block (cLBBB) carried a…
In a prospective multinational cohort of 2,594 heart failure patients across 40 countries, fifteen DNA methylation…
Across 19 studies drawn from nine randomized controlled trials enrolling 10,594 participants, coronary artery bypass…
A 12-week community-based walking intervention called MABIDA enrolled 52 older adults (mean age 73.3±5.7 years) with…
Among 1,113 unpaid informal caregivers of people living with Alzheimer's disease or related dementias (ADRD), 66.5%…
Carrying more than a quarter of the world's tuberculosis burden, India's trajectory toward elimination reveals a…
For the estimated 26 million adults worldwide living with painful diabetic neuropathy — a condition notoriously…
CT130, a semaglutide-derived GLP-1R agonist engineered for biweekly dosing, achieved superior metabolic outcomes…
The GRABS trial is the first randomized controlled study examining tirzepatide (a dual GIP/GLP-1 receptor agonist) as…
Across 10 randomized controlled trials enrolling 6,515 overweight or obese adults, tirzepatide — the dual GIP/GLP-1…
The 2026 European Society of Cardiology guidelines for cardiovascular disease and chronic kidney disease offer a…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.